Genetic Testing for Breast Cancer Pros and Cons Measure
Tiffany Edwards(Fordham University), Heiðdís Valdimarsdóttir(Reykjavík University), Nidhi Kapil‐Pair(Icahn School of Medicine at Mount Sinai), Dana H. Bovbjerg(Icahn School of Medicine at Mount Sinai), Naa Oyo A. Kwate(Icahn School of Medicine at Mount Sinai), Karen Brown(University of Waterloo), Margaret M. McGovern(Icahn School of Medicine at Mount Sinai), Andrea Forman(Fox Chase Cancer Center), Hayley S. Thompson(Albert Einstein College of Medicine), Lina Jandorf(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
The COMPASS study: a longitudinal hierarchical research platform for evaluating natural experiments related to changes in school-level programs, policies and built environment resources
|BMC Public Health|2014|314
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253
Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer
|Journal of Clinical Oncology|2005|239